Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer

被引：5

作者：

Kaya, Dilsa Mizrak ^{[1
,2
]}

Orturk, Bengi ^{[1
]}

Kubilay, Pinar ^{[1
]}

Onur, Handan ^{[1
]}

Utkan, Gungor ^{[1
]}

Senler, Filiz Cay ^{[1
]}

Alkan, Ali ^{[1
]}

Yerlikaya, Halis ^{[1
]}

Koksoy, Elif B. ^{[1
]}

Karci, Ebru ^{[1
,3
]}

Demirkazik, Ahmet

Akbulut, Hakan

Icli, Fikri

机构：

[1] Ankara Univ, Dept Med Oncol, Sch Med, TR-06590 Ankara, Turkey

[2] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Ufuk Univ, Dept Med Oncol, Sch Med, TR-06830 Ankara, Turkey

来源：

FUTURE ONCOLOGY | 2018年 / 14卷 / 15期

关键词：

prognosis; resectable breast cancer; vitamin D; 25-HYDROXYVITAMIN D LEVELS; 1,25-DIHYDROXYVITAMIN-D3; CHEMOTHERAPY; TRIAL; CELLS;

D O I：

10.2217/fon-2017-0608

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Aim: There are inconsistent results about the effects of vitamin D level on breast cancer prognosis. We aimed to investigate the effect of vitamin D levels on the prognosis of resectable breast cancer in a patient group with highly different clothing styles. Patients & methods: A total of 186 breast cancer patients were enrolled in the study. Results: Vitamin D level was sufficient, insufficient and deficient in 17.2, 52.2 and 30.6% of patients, respectively. There was a significant relationship between clothing style and serum 25 (OH) D levels. We could not establish any relation between vitamin D level and tumor characteristics or survival. Conclusion: Vitamin D supplementation can be more important than diagnostic serum vitamin D level on prognosis of breast cancer.

引用

页码：1461 / 1467

页数：7

共 26 条

[1] DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS INDUCED BY 1-ALPHA,25-DIHYDROXYVITAMIN-D3
ABE, E
MIYAURA, C
SAKAGAMI, H
TAKEDA, M
KONNO, K
YAMAZAKI, T
YOSHIKI, S
SUDA, T
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08): : 4990 - 4994
[2] Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[3] Altundag MK, 2010, ASCO ANN M IL US 4 8
[4] Apperly FL, 1941, CANCER RES, V1, P191
[5] Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
Bischoff-Ferrari, Heike A.
Giovannucci, Edward
Willett, Walter C.
Dietrich, Thomas
Dawson-Hughes, Bess
[J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (01) : 18 - 28
[6] Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Charehbili, A.
Hamdy, N. A. T.
Smit, V. T. H. B. M.
Kessels, L.
van Bochove, A.
van Laarhoven, H. W.
Putter, H.
Kranenbarg, E. Meershoek-Klein
van Leeuwen-Stok, A. E.
van der Hoeven, J. J. M.
van de Velde, C. J. H.
Nortier, J. W. R.
Kroep, J. R.
[J]. BREAST, 2016, 25 : 69 - 74
[7] 1,25-DIHYDROXYVITAMIN-D3 AND MALIGNANT-MELANOMA - THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL-GROWTH IN CULTURE
COLSTON, K
COLSTON, MJ
FELDMAN, D
[J]. ENDOCRINOLOGY, 1981, 108 (03) : 1083 - 1086
[8] Vitamin D deficiency and insufficiency prevalence in the west of Ireland-A retrospective study
delos Reyes, J.
Smyth, A.
Griffin, D.
O'Shea, P.
O'Keeffe, S.
Mulkerrin, E. C.
[J]. JOURNAL OF NUTRITION HEALTH & AGING, 2017, 21 (10) : 1107 - 1110
[9] DOKOH S, 1984, CANCER RES, V44, P2103
[10] NORMAL AND MALIGNANT BREAST-TISSUE IS A TARGET ORGAN FOR 1,25-(OH)2 VITAMIN-D3
EISMAN, JA
MACINTYRE, I
MARTIN, TJ
FRAMPTON, RJ
KING, RJB
[J]. CLINICAL ENDOCRINOLOGY, 1980, 13 (03) : 267 - 272

← 1 2 3 →